Literature DB >> 19953555

Comparative protein profiling of serum and plasma using an antibody suspension bead array approach.

Jochen M Schwenk1, Ulrika Igel, Bernet S Kato, George Nicholson, Fredrik Karpe, Mathias Uhlén, Peter Nilsson.   

Abstract

In the pursuit towards a systematic analysis of human diseases, array-based approaches within antibody proteomics offer high-throughput strategies to discover protein biomarkers in serum and plasma. To investigate the influence of sample preparation on such discovery attempts, we report on a systematic effort to compare serum and plasma protein profiles determined with an antibody suspension bead array. The intensity levels were used to define protein profiles and no significant differences between serum and plasma were observed for 79% of the 174 antibodies (targeting 156 proteins). By excluding 36 antibodies giving rise to differential intensity levels, cluster analysis revealed donor-specific rather than preparation-dependent grouping. With a cohort from a clinically relevant medical condition, the metabolic syndrome, the influence of the sample type on a multiplexed biomarker discovery approach was further investigated. Independent comparisons of protein profiles in serum and plasma revealed an antibody targeting ADAMTSL-4, a protein that would qualify to be studied further in association with the condition. In general, the preparation type had an impact on the results of the applied antibody suspension bead array, and while the technical variability was equal, plasma offered a greater biological variability and allowed to give rise to more discoveries than serum.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19953555     DOI: 10.1002/pmic.200900657

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  13 in total

1.  Multiplexed protein analysis using encoded antibody-conjugated microbeads.

Authors:  Nora Theilacker; Eric E Roller; Kristopher D Barbee; Matthias Franzreb; Xiaohua Huang
Journal:  J R Soc Interface       Date:  2011-01-19       Impact factor: 4.118

2.  Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays.

Authors:  Jochen M Schwenk; Ulrika Igel; Maja Neiman; Hanno Langen; Charlotte Becker; Anders Bjartell; Fredrik Ponten; Fredrik Wiklund; Henrik Grönberg; Peter Nilsson; Mathias Uhlen
Journal:  Mol Cell Proteomics       Date:  2010-08-03       Impact factor: 5.911

3.  Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data.

Authors:  Vera Ignjatovic; Philipp E Geyer; Krishnan K Palaniappan; Jessica E Chaaban; Gilbert S Omenn; Mark S Baker; Eric W Deutsch; Jochen M Schwenk
Journal:  J Proteome Res       Date:  2019-10-11       Impact factor: 4.466

Review 4.  Early detection: the impact of genomics.

Authors:  M C J van Lanschot; L J W Bosch; M de Wit; B Carvalho; G A Meijer
Journal:  Virchows Arch       Date:  2017-06-01       Impact factor: 4.064

5.  ProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencing.

Authors:  Spyros Darmanis; Rachel Yuan Nong; Johan Vänelid; Agneta Siegbahn; Olle Ericsson; Simon Fredriksson; Christofer Bäcklin; Marta Gut; Simon Heath; Ivo Glynne Gut; Lars Wallentin; Mats G Gustafsson; Masood Kamali-Moghaddam; Ulf Landegren
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

6.  Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model.

Authors:  Bernet S Kato; George Nicholson; Maja Neiman; Mattias Rantalainen; Chris C Holmes; Amy Barrett; Mathias Uhlén; Peter Nilsson; Tim D Spector; Jochen M Schwenk
Journal:  Proteome Sci       Date:  2011-11-17       Impact factor: 2.480

7.  Circulating carnosine dipeptidase 1 associates with weight loss and poor prognosis in gastrointestinal cancer.

Authors:  Peter Arner; Frauke Henjes; Jochen M Schwenk; Spyros Darmanis; Ingrid Dahlman; Britt-Marie Iresjö; Peter Naredi; Thorhallur Agustsson; Kent Lundholm; Peter Nilsson; Mikael Rydén
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

8.  Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies.

Authors:  Burcu Ayoglu; Amina Chaouch; Hanns Lochmüller; Luisa Politano; Enrico Bertini; Pietro Spitali; Monika Hiller; Eric H Niks; Francesca Gualandi; Fredrik Pontén; Kate Bushby; Annemieke Aartsma-Rus; Elena Schwartz; Yannick Le Priol; Volker Straub; Mathias Uhlén; Sebahattin Cirak; Peter A C 't Hoen; Francesco Muntoni; Alessandra Ferlini; Jochen M Schwenk; Peter Nilsson; Cristina Al-Khalili Szigyarto
Journal:  EMBO Mol Med       Date:  2014-07       Impact factor: 12.137

Review 9.  Clinical proteomics: promises, challenges and limitations of affinity arrays.

Authors:  Christian Betzen; Mohamed Saiel Saeed Alhamdani; Smiths Lueong; Christoph Schröder; Axel Stang; Jörg D Hoheisel
Journal:  Proteomics Clin Appl       Date:  2015-03-02       Impact factor: 3.494

10.  A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.

Authors:  Annemieke W J Opstal-van Winden; Wendy Rodenburg; Jeroen L A Pennings; Conny T M van Oostrom; Jos H Beijnen; Petra H M Peeters; Carla H van Gils; Annemieke de Vries
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.